Medicine

On this episode of Music and Health, David Leventhal and Constantina Theofanopoulou discuss how dance classes can help Parkinson’s patients regain their movement abilities, create connections with other people, and improve their quality of life. What does neuroscience research say about dance as a form of healing?

The highly polarized debate over health care for transgender youth demonstrates why the pursuit of so-called scientific neutrality so often fails to bring about social consensus.

A unique class of scientist-bureaucrats at the National Cancer Institute shows that government science is an asset we can’t afford to lose.

What researching a biography of the celebrated mid-century physician-humanist reveals about technological capability and human frailty.

On this episode of The Ongoing Transformation podcast, host Sara Frueh talks to Georges Benjamin, executive director of the American Public Health Association, about how the US health care system creates disparities and how we can fix them.

For too long, the science and clinical practice of women’s sexual health have been neglected. Changes are needed to improve research agendas, health care worker training, and care protocols.

Has funding for medical research been excluding some science that may have incredible potential to improve human health?

On this episode of Science Policy IRL, Alta Charo discusses her decades of experience formulating and informing policy on new and emerging technology such as stem cells, cloning, and CRISPR. A lawyer and bioethicist by training, she describes what it’s like to be one of the only non-scientists at the science policy table, how helping a close friend who died of ALS continues to inspire her work, and why science policy can help us become techno optimists.

With a smaller budget than hoped for, ARPA-H must focus. Here’s how the new agency can synergize existing government efforts and advance breakthrough technologies that protect us all.

US drug companies turn taxpayer-funded innovation into astronomical profits. A new agency focused on health innovation could shift the rewards of medical advances to benefit public health.